Global Market Access Lead (Late Stage)

Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. 

Over three years ago, we embarked on a transformative journey to become a truly global innovative healthcare company with a leading focus in Gastrointestinal (GI) health. We have experienced remarkable growth, nearly doubling our revenues, expanding geographically, and integrating several key acquisitions. We have also evolved our portfolio, expanded into rare and specialty segments, and strengthened our pipeline and people capabilities. 

But our journey is far from complete! In fact, this is just the beginning of a bold new chapter in Alfasigma's history. We are committed to advancing innovation and leveraging our deep expertise to provide better health and a better quality of life for patients and consumers worldwide, and expand our reach across diverse markets. 

To strengthen our Market Access team, we are looking for an experienced Global Market Access & Pricing lead (Late stage assets).

Scope of the Job

This pivotal global role within the Global Market Access & Pricing (GMAP) team plays a key part in Alfasigma’s strategic expansion into the specialty space. You will support both a ready-to-launch asset and upcoming late-stage assets (Phase II read-out onwards), ensuring their value is clearly demonstrated and recognized across global payer systems.

As part of the GMAP leadership team, you will collaborate closely with the Head of Global Market Access to shape and execute global market access and pricing strategies. This includes designing and implementing evidence-based value demonstration plans, leveraging clinical trial data and complementary real-world evidence to ensure alignment with payer and HTA expectations worldwide.

Your work will focus on developing a value proposition that is:

• Compelling to Health Technology Assessment (HTA) bodies, payers, and payer stakeholders
• Tailored to well-defined patient subpopulations
• Differentiated, evidence-aligned, and future-proofed through robust evidence generation

Your Role

As Global Market Access & Pricing Lead, you will be responsible for defining and driving Alfasigma’s global access and pricing strategy.

Key responsibilities include:
Strategic Design and Implementation

• Lead the design and execution of global value propositions and access strategies
• Align pricing and access assumptions with the asset’s strategic ambition and clinical profile
• Drive payer insight generation to inform value messaging and decision-making
• Continuously adapt strategies to evolving payer landscapes (US, EU, China, Japan, LATAM)
• Co-create evidence generation and health outcomes strategies to support value demonstration
• Challenge and refine global business case assumptions

Global Access Tools Development

• Design and deploy global access and pricing tools (e.g., Global Value Dossiers, Payer Decks, Objection Handlers)
• Enable local adaptation and implementation across markets
• Support evidence generation for HTA submissions, including literature reviews and indirect treatment comparisons (NMA, MAIC, synthetic arms)
• Coordinate health economic and budget impact models
• Train affiliates to ensure global alignment and launch readiness

Cross-Functional Partnership

• Serve as a trusted strategic advisor across internal functions (Global Strategic Marketing, Medical Affairs, Clinical Development, Regulatory Affairs, HEOR, etc.)
• Provide thought leadership in pricing, reimbursement, and access strategy
• Integrate payer and HTA perspectives into cross-functional decision-making

Who are you ?

You are a strategic and analytical market access leader with deep experience navigating the global payer landscape. You combine scientific and economic expertise with strategic agility and a passion for improving patient access to innovative therapies.

Your background includes:

• Advanced degree in a scientific field; MBA and/or advanced degree in Public Policy or Health Economics preferred
• 10+ years of hands-on experience in global market access and pricing across key markets
• Strong understanding of US market access and HTA-driven systems (EU, UK, Canada, Japan, etc.)
• Proven expertise in economic modeling, outcomes research, HTA submissions, and payer negotiations
• Experience across pre-launch, launch, and post-launch activities
• Skilled communicator and influencer with the ability to drive cross-functional alignment
• Exposure to specialty care and rare diseases is highly desirable
• Fluent in English (written and spoken); additional languages a plus
• Willingness to travel and thrive in a dynamic, fast-paced, and growth-oriented environment

What’s in It for You

• Be part of a growing, innovation-driven company entering new therapeutic areas
• Work on global, high-impact projects shaping access to cutting-edge specialty medicines
• Collaborate with a diverse team of scientific, commercial, and policy experts
• Enjoy a high level of autonomy and strategic influence within a global organization
• Opportunities for career growth, international exposure, and leadership development
• Competitive compensation, performance-based incentives, and comprehensive benefits

Why Join Alfasigma?  

At Alfasigma, we foster a culture where the courage to innovate is key to our success. 
We offer a competitive salary, comprehensive benefits, and extensive opportunities for professional growth and development. 

Our commitment to people and patients is at the heart of everything we do. We value diversity and welcome individuals with unique perspectives and experiences. We believe that open-mindedness, collaboration, and a shared passion for innovation are essential to achieving meaningful progress. 

Join Alfasigma and become part of a forward-thinking team dedicated to shaping the future of the pharmaceutical industry.